Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway

Overview of attention for article published in Cancer Cell International, November 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR THE TREATMENT OF GLIOBLASTOMA THAT MINIMIZE RADIATION DAMAGE IN SUSCEPTIBLE…

Application WO-2023129874-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.